Belay Tesfamariam

4.2k total citations
56 papers, 3.4k citations indexed

About

Belay Tesfamariam is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Belay Tesfamariam has authored 56 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 18 papers in Cardiology and Cardiovascular Medicine and 15 papers in Molecular Biology. Recurrent topics in Belay Tesfamariam's work include Nitric Oxide and Endothelin Effects (23 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Coronary Interventions and Diagnostics (8 papers). Belay Tesfamariam is often cited by papers focused on Nitric Oxide and Endothelin Effects (23 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Coronary Interventions and Diagnostics (8 papers). Belay Tesfamariam collaborates with scholars based in United States, Sweden and Germany. Belay Tesfamariam's co-authors include Richard A. Cohen, Michael L. Brown, Ran Cohen, W Halpern, Robert M. Weisbrod, Daniel Deykin, J.A. Jakubowski, Albert DeFelice, James Palacino and George Osol and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Belay Tesfamariam

56 papers receiving 3.3k citations

Peers

Belay Tesfamariam

PHYSI

CCM

SURGE

BIOCH

Livius V. d’Uscio United States

Ulrich Hink Germany

Kiyotaka Kugiyama Japan

Gorka San José Spain

Takayuki Ito Japan

Jeremy D. Ollerenshaw United States

Masao Kakoki United States

Takao Sugiyama Japan

Laurent Loufrani France

M Yoshizumi Japan

Livius V. d’Uscio United States

Belay Tesfamariam

2.2k ×1.4

PHYSI

1.7k ×1.3

CCM

998 ×1.6

357 ×0.7

SURGE

507 ×1.1

BIOCH

Citations per year, relative to Belay Tesfamariam Belay Tesfamariam (= 1×) peers Livius V. d’Uscio

Countries citing papers authored by Belay Tesfamariam

Since Specialization

Citations

This map shows the geographic impact of Belay Tesfamariam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belay Tesfamariam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belay Tesfamariam more than expected).

Fields of papers citing papers by Belay Tesfamariam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belay Tesfamariam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belay Tesfamariam. The network helps show where Belay Tesfamariam may publish in the future.

Co-authorship network of co-authors of Belay Tesfamariam

This figure shows the co-authorship network connecting the top 25 collaborators of Belay Tesfamariam. A scholar is included among the top collaborators of Belay Tesfamariam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belay Tesfamariam. Belay Tesfamariam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tesfamariam, Belay. (2023). Targeting Rho kinase to restore endothelial barrier function following vascular scaffold implantation. Drug Discovery Today. 28(7). 103609–103609. 7 indexed citations

Tesfamariam, Belay. (2019). Targeting heme-oxidized soluble guanylate cyclase to promote osteoblast function. Drug Discovery Today. 25(2). 422–429. 8 indexed citations

Tesfamariam, Belay. (2017). Periadventitial local drug delivery to target restenosis. Vascular Pharmacology. 107. 12–19. 8 indexed citations

Tesfamariam, Belay. (2017). Distinct characteristics of neonatal platelet reactivity. Pharmacological Research. 123. 1–9. 14 indexed citations

Tesfamariam, Belay. (2016). Local arterial wall drug delivery using balloon catheter system. Journal of Controlled Release. 238. 149–156. 23 indexed citations

Tesfamariam, Belay. (2016). Endothelial Repair and Regeneration Following Intimal Injury. Journal of Cardiovascular Translational Research. 9(2). 91–101. 51 indexed citations

Wood, Steven C., et al.. (2015). TCT-511 Bioresorbable polymers and paclitaxel impair endothelial regeneration by induction of autophagy. Journal of the American College of Cardiology. 66(15). B209–B209. 2 indexed citations

Tesfamariam, Belay. (2015). Involvement of platelets in tumor cell metastasis. Pharmacology & Therapeutics. 157. 112–119. 188 indexed citations

Tesfamariam, Belay, et al.. (2011). Induction of Nicotinamide–Adenine Dinucleotide Phosphate Oxidase and Apoptosis by Biodegradable Polymers in Macrophages: Implications for Stents. Journal of Cardiovascular Pharmacology. 57(6). 712–720. 12 indexed citations

10.

Tesfamariam, Belay. (2008). Platelet function in intravascular device implant-induced intimal injury. Cardiovascular revascularization medicine. 9(2). 78–87. 7 indexed citations

11.

Tesfamariam, Belay & Albert DeFelice. (2006). Endothelial injury in the initiation and progression of vascular disorders. Vascular Pharmacology. 46(4). 229–237. 121 indexed citations

12.

Wood, Stephen J., Grace Bushar, & Belay Tesfamariam. (2006). Inhibition of mammalian target of rapamycin modulates expression of adhesion molecules in endothelial cells. Toxicology Letters. 165(3). 242–249. 11 indexed citations

13.

Tesfamariam, Belay. (2006). The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function. American Journal of Cardiovascular Drugs. 6(2). 115–120. 28 indexed citations

14.

Tesfamariam, Belay. (2006). Local vascular toxicokinetics of stent-based drug delivery. Toxicology Letters. 168(2). 93–102. 24 indexed citations

15.

Tesfamariam, Belay, et al.. (1995). Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria. European Journal of Pharmacology. 281(1). 17–20. 5 indexed citations

16.

Tesfamariam, Belay, et al.. (1994). β₁‐ and β₂‐adrenoceptor antagonist activities of ICI‐215001, a putative β₃‐adrenoceptor agonist. British Journal of Pharmacology. 112(1). 55–58. 21 indexed citations

17.

Tesfamariam, Belay, James Palacino, Robert M. Weisbrod, & Richard A. Cohen. (1993). Aldose Reductase Inhibition Restores Endothelial Cell Function in Diabetic Rabbit Aorta. Journal of Cardiovascular Pharmacology. 21(2). 205–205. 83 indexed citations

18.

Tesfamariam, Belay, Melissa Brown, & R. A. Cohen. (1992). Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 153–157. 33 indexed citations

19.

Tesfamariam, Belay, Robert M. Weisbrod, & Richard A. Cohen. (1992). Cyclic GMP Modulators on Vascular Adrenergic Neurotransmission. Journal of Vascular Research. 29(5). 396–404. 14 indexed citations

20.

Tesfamariam, Belay & William Halpern. (1988). Asymmetry of responses to norepinephrine in perfused resistance arteries. European Journal of Pharmacology. 152(1-2). 167–170. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact